SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004111
Filing Date
2021-11-10
Accepted
2021-11-10 16:25:47
Documents
87
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20210930.htm   iXBRL 10-Q 3208774
2 EX-31.1 acet-ex31_1.htm EX-31.1 17582
3 EX-31.2 acet-ex31_2.htm EX-31.2 18053
4 EX-32.1 acet-ex32_1.htm EX-32.1 14433
  Complete submission text file 0000950170-21-004111.txt   11395822

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20210930_lab.xml EX-101.LAB 593701
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acet-20210930_cal.xml EX-101.CAL 63611
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20210930_pre.xml EX-101.PRE 455966
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20210930_def.xml EX-101.DEF 278048
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20210930.xsd EX-101.SCH 80787
10 EXTRACTED XBRL INSTANCE DOCUMENT acet-20210930_htm.xml XML 2205014
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 211397062
SIC: 2834 Pharmaceutical Preparations